The recall at
Nature’s Pharmacy has been initiated due to concerns associated with quality control procedures that present a potential risk to sterility assurance.
EMPR notes issues were observed during a recent U.S. Food and Drug Administration (FDA) inspection.
According the
Medwatch service, the products of concern were supplied to the offices of licensed medical professionals and to patients by prescription within the pharmacy's local market area in North Carolina. The medications were distributed from January 1, 2013 through to November 2013.
In addition to the recall, Nature's Pharmacy has decided to cease production of all sterile products.
